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Sprouty proteins function as negative regulators of the receptor tyrosine kinase (RTK)-mediated Ras/Raf/
MAPK pathway in many varied physiological and developmental processes, inhibiting growth factor-
induced cellular proliferation, migration and differentiation. Like other negative regulators, Sprouty
proteins are expressed in various organs during development, including the eye; ubiquitously expressed
in the optic vesicle, lens pit, optic cup and lens vesicle. Given the synexpression of different antagonists
(e.g, Sprouty, Sef, Spred) in the developing lens, to gain a better understanding of their speciﬁc role, in
particular, their ability to regulate ocular growth factor signaling in lens cells, we characterized trans-
genic mice overexpressing Sprouty1 or Sprouty2 in the eye. Overexpression of Sprouty in the lens re-
sulted in reduced lens and eye size during ocular morphogenesis, inﬂuenced by changes to the lens
epithelium, aberrant ﬁber cell differentiation and compromised de novo maintenance of the lens capsule.
Here we demonstrate an important inhibitory role for Sprouty in the regulation of lens cell proliferation
and ﬁber differentiation in situ, potentially through its ability to modulate FGF- (and even EGF-) medi-
ated MAPK/ERK1/2 signaling in lens cells. Whilst growth factor regulation of lens cell proliferation and
ﬁber differentiation are required for orchestrating lens morphogenesis and growth, in turn, antagonists
such as Sprouty are just as important for regulating the intracellular signaling pathways driving lens
cellular processes.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Sprouty (Spry) proteins function as key regulators of various
physiological and developmental processes, including angiogen-
esis, lung morphogenesis, limb formation, and bone, kidney, eye
and wing development (Chi et al., 2004; Impagnatiello et al., 2001;
Lee et al., 2001; Mailleux et al., 2001; Minowada et al., 1999; Tefft
et al., 1999; Yigzaw et al., 2001). In common with other negative
regulators, including Sef and Spreds (Sprouty-related proteins),
members of the Spry protein family repress the receptor tyrosine
kinase (RTK)-mediated Ras/Raf/MAPK pathway (Bundschu et al.,
2007; Cabrita and Christofori, 2008; Mason et al., 2006; Ron et al.,
2008), and are reported to inhibit growth factor-induced cellular
proliferation, migration and differentiation (Gross et al., 2001; Lee
et al., 2004; Yigzaw et al., 2001). In mammals, Spry proteinsnd Histology, Bosch Institute,
vicu).
niversity of Sydney, NSW,negatively regulate high afﬁnity RTK-signaling, such as FGF re-
ceptor- (Gross et al., 2001; Hanafusa et al., 2002) and PDGF-re-
ceptor signaling (Gross et al., 2001; Yigzaw et al., 2001). This in-
hibitory function of Spry is directed at numerous levels of the Ras/
ERK pathway, such as Grb2, FRS2, C-Raf and Shp2 (Kim and Bar-
Sagi, 2004; Mason et al., 2006). In some cellular contexts; how-
ever, different Spry isoforms (e.g. Spry2) are reported to enhance
EGF-mediated signaling (Egan et al., 2002; Wong et al., 2002), by
interfering with the c-Cbl-mediated ubiquitylation and degrada-
tion of the EGF receptor (Levkowitz et al., 1998; Rubin et al., 2003;
Soubeyran et al., 2002; Wong et al., 2001).
Similar to Sef and Spred, Spry proteins are expressed in various
organs, including the eye (Boros et al., 2006; Zhao et al., 2015). In
rodents, Spry1 and Spry2 transcripts are expressed ubiquitously in
the optic vesicle at embryonic day 9.5 (E9.5); the lens pit and optic
cup at E10.5; and the lens epithelium and primary lens ﬁbers at
E12.5 (Boros et al., 2006). By E15.5, Spry1 mRNA expression is
mainly restricted to the lens epithelium and the early secondary
lens ﬁbers, and persists throughout fetal and postnatal lens
growth. The expression pattern of Spry2 transcripts is similar to
that of Spry1 during early ocular morphogenesis, ubiquitously
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from E9.5 to E12.5 (Boros et al., 2006). In contrast to Spry1, from
E13.5 until early postnatal age P3, Spry2 transcripts are detected
both in the lens epithelium and the entire ﬁber cell mass. With
further postnatal growth, Spry2 mRNA expression in the primary
ﬁbers progressively disappears, with expression limited to the lens
epithelium and early secondary ﬁbers, decreasing with age (Boros
et al., 2006).
Of the many growth factors present in the ocular environment,
FGF is one of the key molecules to induce both lens epithelial cell
proliferation and ﬁber differentiation (see Lovicu and McAvoy,
2005). Our earlier studies reported that overexpression of Sef in
lens of mice could block ﬁber cell elongation associated with its
differentiation, repressing lens and eye growth (Newitt et al.,
2010). These ﬁndings were reminiscent of lenses deﬁcient for
FGFR1-3 (Zhao et al., 2008), both displaying a similar phenotype.
Given the overlapping patterns of expression of Sef with Spry in
the developing lens, to gain a better understanding of the role of
these different antagonists in lens development, in particular, their
ability to regulate ocular growth factor signaling in lens cells, we
generated transgenic mice overexpressing Spry1 or Spry2 in the
eye. Whilst our earlier studies reported little response in lens of
transgenic mice hemizygous for the Spry1 transgene (Shin et al.,
2012); here we demonstrate that higher levels of Spry1 expression
in the lens (in transgenic mice homozygous for the Spry1 trans-
gene), inﬂuences lens cellular processes and subsequent lens and
eye growth, similar to overexpression of Spry2, but different to
that previously reported for Sef (Newitt et al., 2010). Whilst
growth factor regulation of lens cell proliferation and ﬁber dif-
ferentiation are required for orchestrating lens morphogenesis and
growth, in turn antagonists such as Spry and Sef are just as im-
portant for regulating the intracellular signaling pathways driving
lens cellular processes.2. Materials and methods
All animal procedures were carried out in accordance with the
National Health Medical Research Council (Australia) guidelines
and the Association for Research in Vision and Ophthalmology
Handbook for the Use of Animals in Biomedical Research (USA). All
protocols were approved by the Animal Ethics Review Committee
of the University of Sydney, Australia.
2.1. Animals
The different Cre-expressing lines of mice (Le-Cre and MLR10-
Cre) were provided by Dr. Michael Robinson. For the Le-Cre line,
Cre-recombinase is expressed in the developing lens, cornea,
conjunctiva and skin of the eyelids from E9 (Ashery-Padan et al.,
2000), while Cre-expression in the MLR10-Cre line is restricted to
the lens epithelial and ﬁber cells (Zhao et al., 2004). To overexpress
Spry2 in the eye, these Cre-lines were crossed to MS2GOF (in-
ducible Spry 2 gain of function) transgenic mice, provided by Dr.
Gail Martin (Basson et al., 2008). For simplicity, the resultant mice
from these crosses will be referred to as Spry2GOF. Only transgenic
mice heterozygous for both the MS2GOF and Le-Cre transgene
were characterised here, given those crossed to MLR10-Cre de-
monstrated a similar lens phenotype. The Spry1 overexpressing
transgenic lines (LOV28–LOV31) were generated on a FVB/N
background as previously described using a modiﬁed αA-crystallin
promoter, fused to a chick δ1-crystallin enhancer element (Shin
et al., 2012). For consistency, we will refer to these as Spry1GOF.
Genotypes were determined by PCR assays using tail DNA as a
template, as previously described (Ashery-Padan et al., 2000; Zhao
et al., 2004; Basson et al., 2008; Shin et al., 2012). For lens explantstudies, the ocular tissues were obtained from either the different
lines of transgenic mice or postnatal albino Wistar rats.
2.2. Histological processing
Whole eyes of postnatal animals ranging in age from postnatal
day 0 (P0) to P21 were ﬁxed in 10% (v/v) neutral-buffered formalin
(NBF, Fronine Laboratory Supplies, Australia), and processed for
parafﬁn embedding (Excelsior ES tissue processor, Thermo Scien-
tiﬁc, MA, USA). Tissue sections were mid-sagittally cut at 6 μm,
and routinely stained with either Haematoxylin and Eosin (H&E)
or Periodic-Acid Schiff (PAS). Tissues were visualized with bright
ﬁeld microscopy (Leica DMLB; Germany) and digitally photo-
graphed (QCapture, QImaging; BC, Canada). As required, images
taken from up to ﬁve mid-sagittal sections of lenses from four
different eyes for each of the different lines of mice, were used to
calculate the average number of lens epithelial cells, and Student's
t-test was performed for statistical evaluation.
2.2.1. Preparation of lens epithelial explants
All tissue culture was performed in Medium 199 with Earle's
salts (M199; Invitrogen, CA, USA). M199 was supplemented with
0.1 mg/ml L-glutamine, 50 U/ml penicillin, 50 mg/ml streptomycin,
2.5 mg/ml amphostat B (Thermo Electron, MA, USA) and 0.1% tissue
culture grade BSA (Sigma-Aldrich, Australia). Eyes from either P7
WT, Spry1GOF, Spry2GOF or postnatal day 10 (P10) wistar rats were
used to obtain lenses, that were subsequently dissected to isolate
the lens epithelium as previously described (Lovicu and McAvoy,
2008). All growth factors applied to lens explants were prepared
as per manufacturer's instructions. Human recombinant FGF2
(R&D Systems; MN, USA) was used at concentrations of 5 ng/ml,
50 ng/ml, or 100 ng/ml. EGF (R&D Systems) was used at a con-
centration of 50 ng/ml or 100 ng/ml. Explants were cultured in the
presence of growth factors from 20 min to up to 10 days. Some
explants were treated with selective inhibitors for PI3-K signaling
(25 mM LY294002; Calbiochem, CA, USA), or dimethyl sulfoxide
(DMSO, control dishes), as previously described (Iyengar et al.,
2006). Cultured explants were either collected fresh for protein
extraction for western blot analysis, or ﬁxed in 10% NBF, pre-em-
bedded in 3% agar in PBS before parafﬁn embedding, sectioning
and staining, as described earlier for histological processing.
2.3. DNA transfection of lens epithelial explants
Rat lens epithelial explants were transfected with DNA plas-
mids of interest (pLXSG, pLXSG-Sprouty1, pLXSG-Sprouty2,
pLXSG-ΔSprouty2 and pLXSG-dnFGFR) using Lipofectamine 2000
(Invitrogen, USA) as previously described (Zhao et al., 2015).
Transfected cells in explants expressed the reporter gene, en-
hanced-GFP, and were visualized and photographed using an in-
verted epi-ﬂuorescence microscope (Olympus CK2; Tokyo, Japan).
Upon transfection, explants were treated with or without 100 ng/
ml FGF2 for up to 5 days. The number of labeled lens epithelial
cells that elongated (from up to 20 explants for each of the dif-
ferent treatments) were blind counted and Student's t-test was
performed for statistical evaluation.
2.4. Immunoﬂuorescent labeling of lens epithelial explants
At the end of the culture period, explants were ﬁxed in 10% NBF
for 20 min for immunoﬂuorescent labeling as previously described
(Lovicu and McAvoy, 2001). In brief, explants were permeabilised
in PBS/Tween-20, blocked with 3% normal goat serum before in-
cubating overnight with primary antibody of interest at 4 °C in a
humidiﬁed chamber. On the following day, explants were rinsed
with PBS and incubated with a secondary antibody at room
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of propidium iodide (Invitrogen; CA, USA) for 15 min to label cell
nuclei, or 30 mg/ml of TRITC-conjugated lectin (Sigma-Aldrich;
Australia) for 20 min to label cell membranes. Explants were then
mounted in 10% PBS in glycerol and viewed under epi-ﬂuores-
cence (Leica-DMLB and Leica DC-180; Germany) or with a LSM5
Pascal confocal microscope (Carl Zeiss; USA). Primary antibodies
included anti-β-crystallin (diluted 1:50), and anti-pERK1/2 (Cell
Signaling Technologies, USA, diluted 1:100). Anti-rabbit Cy3 (di-
luted 1:200; Sigma-Aldrich; Australia), anti-mouse Alexa Fluor
594 (diluted 1:1000; Invitrogen; CA, USA), and anti-mouse Alexa
Fluor 499 (diluted 1:1000; Invitrogen; CA, USA) were used as
secondary antibodies.
2.5. Immunoﬂuorescent labeling of parafﬁn sections
Parafﬁn sections were deparafﬁnised and hydrated as pre-
viously described (Shin et al., 2012). Antigen retrieval was required
to label for Spry1, Spry2, and pERK1/2. For this, sections were
immersed in 10 mM sodium citrate buffer (pH6) and autoclaved at
121 °C for 10 min, cooled to RT and immunolabeled as follows.
Sections were blocked with 3% NGS before application of primary
antibody overnight at 4 °C in a humidiﬁed chamber. Anti-Spry1
(Santa Cruz Biotechnology; CA, USA), and anti-Spry2 (Santa Cruz
Biotechnology) were diluted 1:200. Anti-pERK1/2 and anti-cleaved
caspase-3 (Cell Signaling Technology; MA, USA) were diluted
1:100. Anti-β- and γ-crystallins were diluted 1:50. After rinsing
with PBS, slides were incubated with appropriate secondary an-
tibodies for 2 h at RT in a dark humidiﬁed chamber. Anti-rabbit
Cy3 (diluted 1:200; Sigma-Aldrich; Australia), anti-mouse Alexa
Fluor 594 (diluted 1:1000; Invitrogen; CA, USA), and anti-mouse
Alexa Fluor 499 (diluted 1:1000; Invitrogen; CA, USA) were used.
Slides were then counterstained with 1 mg/ml bisbenzimide
(Hoechst dye; Calbiochem; CA, USA) for 15 min at RT to label cell
nuclei. After a ﬁnal rinse in PBS, slides were mounted and viewed
under epi-ﬂuorescence (Leica-DMLB; Germany), and photo-
graphed (QCapture, QImaging; BC, Canada).
2.6. BrdU-labeling and tracking
To determine the rate of lens epithelial cell proliferation and
the fate of these cells following incorporation of BrdU, P2 mice
from WT, Spry1GOF or Spry2GOF were intraperitoneally injected
with BrdU (1 mg/10 g body weight) and sacriﬁced after 2 h or after
7 days (at P9). Eyes were processed for parafﬁn embedding, and
were immunolabelled for BrdU as previously described (Kallifati-
dis et al., 2011). The BrdU-tagged lens epithelial cells were counted
relative to total number of lens epithelial cells to determine the
rate of lens cell proliferation, and the Kruskal–Wallis test was
performed for statistical evaluation. Moreover, BrdU-tagged epi-
thelial cells that had migrated posteriorly, pass the lens fulcrum
(equator) into the lens ﬁber cortex after 7 days were also counted
for each line of mice, and Student's t-test was performed for sta-
tistical evaluation.
2.7. Western blotting
Western blotting was carried out as previously described
(Iyengar et al., 2006). In brief whole lens (isolated from sur-
rounding eye tissue) or lens explants (following treatment period)
were pooled and lysed in buffer [2.5 mM EDTA, 25 mM Tris,
375 mM NaCl, 1.5 mM NaVO3, 1% (v/v) IGEPAL CA-630 (Sigma-
Aldrich, Australia) and Complete mini-protease inhibitor cocktail
tablet (Roche Diagnostics, Germany) in Milli-Q water]. Following
centrifugation, Micro BCA protein assay reagent kit (Pierce, IL,
USA) was used to determine the protein concentration of thesoluble fractions. The protein samples were loaded onto SDS-PAGE
acrylamide gel with a pre-stained protein molecular weights lad-
der (Invitrogen; CA, USA). Gels were electrophoresed and proteins
transferred to PVDF membranes for blotting. Membranes were
blocked with skim milk powder, and incubated with primary an-
tibody at 4 °C, overnight. Antibodies against Spry1 or Spry2 (Santa
Cruz, CA, USA) were diluted 1:500. Antibodies against pERK1/2 or
pAKT (Cell signaling technologies, USA) were diluted 1:2000.
Those against total Erk1/2 or total Akt (Cell signaling technologies,
USA) were diluted 1:1000. GAPDH (HyTest, Finland) was used as
the loading control at a 1:20,000 dilution. On the following day,
membranes were rinsed and incubated with the appropriate sec-
ondary antibody at RT for 2 h. For GAPDH, rabbit anti-mouse IgG
conjugated to horseradish peroxidase (HRP; Zymed, CA, USA) was
used at 1:10,000 dilution. For all other primary antibodies, goat
anti-rabbit HRP-conjugate IgG (Cell Signaling Technologies, USA)
was used at 1:5000 dilution. After rinsing, the membranes were
incubated in Immobilon Western Chemiluminescent HRP Sub-
strate (Millipore; MA, USA) for 5 min and signals were detected
with Alpha Innotech FluorChem SP Imaging System (Cell Bios-
ciences; CA, USA). For re-labeling of Western blots, the PVDF
membranes were stripped with Stripping Buffer [6.25 mM Tris–
HCl, 69 mM SDS, 100 mM β-mercaptoethanol in deionised water]
for 20 min at 55 °C. After rinsing, the membranes were once again
blocked and immunolabelled as described earlier. Densitometry
was used to quantify and compare the protein label of different
samples on a Western blot using Alpha Innotech FluorChem SP
Imaging System (Cell Biosciences; CA, USA). Student's t-test were
performed for statistical evaluation.3. Results
3.1. Spry overexpression in the lens
A number of different lines of transgenic mice overexpressing
Spry1 in the lens were generated (LOV28, LOV29, LOV30 and
LOV31), all demonstrating increased levels of Spry1 protein in the
neonatal murine lens relative to the endogenous levels of Spry1 in
wild type lens (Fig. 1). This marked increase in Spry1 expression
was conﬁrmed using western blotting and densitometry (data not
shown), with transgenic line LOV28 expressing relatively higher
levels of Spry1 at postnatal day 21 (P21; 1.4–1.8 times the level of
that of other Spry1 lines), hence we have used this line, referred to
as Spry1GOF, for most of the data presented. The endogenous levels
of Spry1 protein in the WT neonatal lens were relatively very low
(Fig. 1B), compared to the marked increase in levels of Spry1 in the
lens epithelium and ﬁbers of Spry1GOF mice (Fig. 1D). The levels of
Spry2 protein in P21 transgenic mouse (Spry2GOF) lens was also
markedly increased as determined by densitometry of western
blots (5-fold), compared to the WT lens (Fig. 1J). This was con-
ﬁrmed using immunoﬂuorescence for Spry2 in the neonatal lens
of Spry2GOF transgenic mice (Fig. 1H). Given the strong label for
Spry2 in the WT lens epithelium (Fig. 1F), any increase in Spry2
levels in lenses of the Spry2GOF mice was difﬁcult to detect;
however, an increase in expression of Spry2 levels was readily
apparent at the transitional zone, and in early secondary ﬁber cells
(Fig. 1H, asterisk).
3.2. Histology
We compared the histology of postnatal lenses from Spry1GOF
and Spry2GOF transgenic mice lines to WT mice (or only Cre-po-
sitive lines), at postnatal ages P0, P5 and P10 (Figs. 2–5). For the
purpose of this study, we only characterized transgenic mice
homozygous for the Spry1GOF transgene, as heterozygous mice did
Fig. 1. Elevated expression of Spry1 and Spry2 in neonatal (P0) lens of Spry1GOF
and Spry2GOF transgenic mice. Compared to the relatively low levels of Spry1 de-
tected in the WT lens (A, B), Spry1 protein levels are markedly higher in lenses of
Spry1GOF mice (C, D). The levels of Spry2 protein in Spry2GOF transgenic mouse are
also elevated, in particular at the transitional zone and in cortical ﬁbers (G, H, as-
terisk), compared to WT lens levels (E, F), consistent with western blotting analysis
of the P21 lenses (J; LC, protein loading control). Scale bar, 50 mm.
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For the Spry2GOF transgenic line, we characterised only lenses from
animals heterozygous for both the MSGOF and Le-Cre (or MLR10-
Cre; see Figs. 2–4), that presented a similar lens phenotype re-
gardless of the Cre-recombinase line used.
A pronounced phenotype of the Spry1GOF and Spry2GOF trans-
genic mice was the smaller size of the lens, compared to the WT
lens (see Figs. 2 and 3); and this was readily observed from
postnatal day 0 (P0, Fig. 2B and C), P5 (Fig. 3C and E) and P10(Fig. 3D and F), consistent with the fact eyes were microphthalmic.
From postnatal day 0, at higher magniﬁcation, we note only subtle
changes in the epithelia of the Spry1GOF and Spry2GOF transgenic
mice lenses, when compared to the WT lenses (Fig. 2G–I). One of
the initial changes observed in the Spry1GOF and Spry2GOF lenses at
this age was a modest reduction in height of the central epithelial
cells (Fig. 2H and I). This diminished cell height was also notice-
able in the peripheral lens epithelium of the Spry2GOF lens (Fig. 2L)
but not so much in the Spry1GOF lens (Fig. 2K), when compared to
the WT lens (Fig. 2J). Early secondary lens ﬁber cell differentiation
was also somewhat compromised at P0, more prominently in the
Spry2GOF mice that lacked an ordered lens bow region, based on
the irregular displacement and positioning of the secondary lens
ﬁber cell nuclei (Fig. 2F and L), compared to the WT and Spry1GOF
mice (Fig. 2D, E, J and K).
By P5 (Figs. 3 and 4), the early secondary ﬁbers of the Spry2GOF
lens appeared fewer in number (fewer cell nuclei) and were still
not arranged in a coordinated manner (Figs. 3E and 4F) as seen in
the bow region of the WT and Spry1GOF lens (Figs. 3A, C and 4D, E).
Moreover, there were prominent irregular-shaped acellular va-
cuoles in the lens cortex of the Spry2GOF mice, that further dis-
rupted the alignment of the secondary lens ﬁber cells (Figs. 3E and
4F). As the lens matured at P5, the central epithelial cell height
reduction in the Spry1GOF and Spry2GOF (Fig. 4B and C) lines was
more pronounced, supported by cell nuclei adopting a more ﬂat-
tened shape. This thinning epithelia persisted at P10 (data not
shown), with a signiﬁcantly thinner lens epithelium in the
Spry2GOF (9.070.6 mm) lens, but not Spry1GOF (10.071.0 mm) lens,
compared to the WT lens (1371.0 mm; Student's t-test; n¼8;
Spry1GOF p40.07, Spry2GOF po0.002). At P5 and P10, the per-
ipheral epithelium of the Spry2GOF lens (see Fig. 4F) was also
thinner than the WT lens epithelium (Fig. 4D); however, the per-
ipheral epithelium of the Spry1GOF lines (Fig. 4E) appeared similar
in thickness to that of the WT lens (Fig. 4D).
Common to both Spry1GOF and Spry2GOF transgenic mice lenses
was the rupture of the posterior lens capsule by P10 (Fig. 3D and F,
arrowheads). Unique to the Spry1GOF lens; however, was the dis-
placement of the transitional zone at P10, with lens epithelia ex-
tending more posteriorly (Fig. 3D, arrows, 3D′). The multiple ir-
regular, acellular vacuoles in the lens ﬁber cortex of the Spry2GOF
lens also persisted at P10 (Fig. 3) and were further exacerbated by
P21 (data not shown). These cortical vacuoles present in the
Spry2GOF line were also observed at P21 in the Spry1GOF line but
were not as severe (data not shown).
3.3. Lens capsule modiﬁcation
Given that the lens of both the Spry1GOF and Spry2GOF lines
rupture by P10 (Fig. 3), we examined for changes in the thickness
of both the anterior and posterior lens capsule with age. At P0
(Fig. 5A–F) and P5 (Fig. 5G–M), the anterior capsule of both
Spry1GOF and Spry2GOF lenses were similar in thickness to that of
the WT lens (compare Fig. 5A, C, E and G, J, L). By P10, the anterior
lens capsule of the Spry1GOF lens (Fig. 5P), appeared thicker
(3.970.3 mm) than that of the WT lens (3.6 mm70.4; see Fig. 5N),
at the time of posterior lens capsule rupture (Fig. 5Q), but this was
not signiﬁcant (Student's t-test; n¼18; p40.5). In contrast, the
anterior lens capsule of the Spry2GOF lens at P10 (Fig. 5R) was
signiﬁcantly thinner (2.170.1 mm; Student's t-test; n¼18;
po0.0003) than that of the WT lens (Fig. 5N), persisting at P21
(data not shown). The posterior lens capsule of both Spry1GOF and
Spry2GOF lenses at P0 (Fig. 5D and F), similar to the anterior lens
capsule, appeared normal in thickness compared to the WT lenses
(Fig. 5B). At P5, the thinning of the posterior lens capsule of the
Spry1GOF line was evident (Fig. 5K), whilst the Spry2GOF posterior
lens capsule appeared relatively normal (Fig. 5M). By P10, the
Fig. 2. Representative H&E staining of postnatal-day-0 (P0) WT mice lens, and Spry1GOF and Spry2GOF transgenic mice lens. The lenses/eyes of Spry1GOF (B, E, H, K) and
Spry2GOF (C, F, I, L) transgenic mice lines when compared to WT lens/eyes (A, D, G, J) were smaller with what appeared to be thinner epithelia (H, I). In the Spry2GOF lens, the
lens bow zones were disrupted at the lens equator (F, shown at higher magniﬁcation, L), compared to that seen in WT (D, J) and Spry1GOF (E, K) lenses. Scale bar, A–C,
400 mm; D–F, 200 mm; G–I, J–L, 50 mm.
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thinned and ruptured (Fig. 5Q and S), leading to the extrusion of
the lens ﬁber content into the vitreous chamber (see Fig. 3).
To determine whether a reduction in PI3K-signaling in lens
cells could compromise the maintenance of lens capsule, we used
a selective phosphatidylinositol 3-kinase (PI3K) inhibitor
(LY294002) on rat lens epithelial explants treated with or without
FGF, as previously described (Iyengar et al., 2007; Wang et al.,
2009). We show that PI3K-signaling is required for new lens
capsule synthesis in vitro, evident by a band of differentially
stained newly deposited extracellular matrix (Fig. 6A–D, arrows).
Explants pre-treated with the PI3K-inhibitor displayed a sig-
niﬁcantly (Student's t-test; n¼14; po0.0001) thinner lens capsule
(3.770.2 mm) to those not treated (only DMSO-treated) with the
inhibitor (4.870.8 mm) after 5 days culture with FGF. Similarchanges in thickness were noted with control explants (no growth
factor treatment) in the absence (only DMSO-treated,
4.770.2 mm) or presence (3.870.4 mm) of LY294002. The thinner
capsule in explants treated with inhibitor (Fig. 6B and D) was due
to the absence of the inner layer of newly synthesized lens capsule
material (Fig. 6A and C, arrows), consistent with a role for PI3K-
signaling in protein synthesis and basement membrane formation
(see Li et al. (2001a, 2001b), Engelman et al. (2006)). Interestingly,
in the presence of LY294002, lens epithelial cells also appeared
less cuboidal as they ﬂattened and spread over the lens capsule
(see Fig. 6B and D). To determine whether overexpression of Spry
potentially led to reduced PI3K-signaling in lens, hence reduced
capsule synthesis and subsequent rupture, we used western
blotting to compare the levels of phosphorylated Akt (pAkt) in
lenses of both Spry1GOF and Spry2GOF with WT lens (Fig. 6E). In
Fig. 3. Representative H&E staining of WT mice lens, and Spry1GOF and Spry2GOF transgenic mice lens. The lenses of WT (A,B), and Spry1GOF (C,D) and Spry2GOF (E, F)
transgenic mice lines were compared at P5 (A, C, E) and P10 (B, D, F). At P5, smaller-sized lenses were noted for both Spry1GOF and Spry2GOF transgenic mice with posterior
lens capsule rupture (arrowheads) of lenses by P10. In the Spry1GOF lens, the transitional and bow zones (arrows) were located far more posterior to the lens equator (shown
at higher magniﬁcation, D′), than that seen in WT lens. In the Spry2GOF lens, there were irregular, acellular vacuoles present in the lens ﬁber cortex (*). Furthermore, in the
Spry2GOF lens, the denucleation in the early secondary ﬁbers appeared disorganized. Scale bar, A–F, 200 mm; D′, 100 mm.
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peared to be slightly lower levels for pAkt in the Spry1GOF and
Spry2GOF lenses compared to that of the WT lens (Fig. 6E), this was
not a signiﬁcant difference. Both pAkt and total Akt levels were
corrected for the GAPDH levels with the ratio of pAkt against total
Akt levels in the WT lens set to equal 1. The ratio obtained from
the transgenic lenses compared to WT, was 0.89 and 0.97 for
Spry1GOF and Spry2GOF, respectively (Fig. 6F), not signiﬁcantly
different from that of the WT lens (student's t-test; Spry1GOF
p40.1; Spry2GOF p40.4).
3.4. Lens ﬁber differentiation
The histology of the transgenic lenses demonstrated a promi-
nent defect in lens ﬁber differentiation, prior to disruption of the
lens epithelium and also prior to lens rupture, especially in mice
overexpressing Spry2 (Spry2GOF; Fig. 3). Immunolabeling for β-
crystallin in neonatal WT, Spry1GOF and Spry2GOF lenses demon-
strated normal patterns of β- (Fig. 7) and γ-crystallin (data not
shown) accumulation. Irrespective of this, the resultant transgeniclenses were smaller in size, questioning whether lens cells over-
expressing Spry were compromised in their ability to respond
normally to ﬁber differentiation stimuli. To test this, epithelial
explants prepared from lenses of WT, Spry1GOF and Spry2GOF mice
were cultured for up to 10 days with a ﬁber-differentiating dose of
FGF2 (Fig. 8). Using lectin staining to demonstrate differences in
cell shape changes, consistent with the in situ data, we observed
that lens cells overexpressing Spry2 (Spry2GOF) did not effectively
elongate and differentiate into ﬁber cells (Fig. 8J and K), unlike lens
cells from WT and Spry1GOF mice that elongated in response to
FGF (Fig. 8A, B, E and F). These lens explant tissues all expressed
increased levels of β-crystallin when treated with FGF after 10 days
(data not shown); however, there were more pronounced differ-
ences in their ability to accumulate β-crystallin by 5 days culture.
After 5 days culture, there were fewer β-crystallin-labeled cells in
FGF-treated lens explants prepared from the Spry1GOF (Fig. 8H,
arrows) and Spry2GOF (Fig. 8M, arrows) mouse lines, compared to
WT lens (Fig. 8D, arrows), indicating a delayed and impaired dif-
ferentiation response to FGF.
To further support that overexpression of Spry1 or Spry2 in lens
Fig. 4. Representative H&E staining of WT mice lens, and Spry1GOF and Spry2GOF
transgenic mice lens at P5 (A–F). At P5, the central lens epithelial cells of the
Spry1GOF (B, E), and Spry2GOF (C, F) transgenic mice lines had markedly reduced cell
height, compared to that of the WT lens (A, D). Apart from this, the Spry1GOF lens
appeared similar to the WT lens. In the Spry2GOF line, the diminished cell height
was also observed in the peripheral lens epithelium (F), together with irregular-
shaped, acellular vacuoles (*) in the lens ﬁber cortex. Scale bar, 50 mm.
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we transfected cells in rat lens epithelial explants to overexpress
Spry1 or Spry2 (Fig. 9). Spry cDNA was inserted into the pLXSG
vector containing an enhanced green ﬂuorescent protein (EGFP)Fig. 5. PAS staining of the lens capsule of WT mice, and Spry1GOF (S1) and Spry2GOF (S2)
capsule (left panels) of the Spry1GOF (C, J, P) and Spry2GOF (E, L, R) transgenic mice wer
thickness to the WT lens at P0 and P5, but slightly thicker at P10, albeit not signiﬁcantly d
Spry2GOF lens (R); however, was signiﬁcantly thinner (2.170.1 mm; Student's t-test; n¼1
panels) of WT mice (B, H, O), and Spry1GOF (D, K, Q) and Spry2GOF (F, M, S) transgenic
Spry1GOF lenses was thinner than that of the WT and Spry2GOF; however, by P10, both preporter gene, to generate pLXSG-Spry1 or pLXSG-Spry2. Without
any growth factor treatment, lens epithelial cells transfected with
pLXSG, pLXSG-Spry1 or pLXSG-Spry2 remained as cuboidal epi-
thelial cells after 5 days of culture (Fig. 9A, C, and E). Once these
transfected cells were treated with a differentiating dose of FGF2
for 5 days, most lens epithelial cells transfected with pLXSG
elongated (Fig. 9B and G). In comparison, a substantial sub-po-
pulation of cells transfected with pLXSG-Spry1 or pLXSG-Spry2
did not elongate (Fig. 9D, F, and G). The percentage of cells
transfected with pLXSG, pLXSG-Spry1 and pLXSG-Spry2 that un-
derwent cell elongation was recorded as 63.7%, 31.9% and 32.9%,
respectively (Fig. 9G), a signiﬁcant reduction in FGF-induced ﬁber
cell elongation with either pLXSG-Spry1 or pLXSG-Spry2 (Stu-
dent's t-test; po0.005).
The speciﬁcity of pLXSG-Spry2 is highlighted by similar ex-
periments replacing the intact Spry2 cDNAwith a mutated form of
Spry (ΔSpry), where cells retained their ability to elongate in re-
sponse to FGF (Fig. 10H), similar to cells not overexpressing Spry2
(Fig. 10B). Cells overexpressing Spry2 (pLXSG-Spry2) had impaired
FGF-induced ﬁber cell elongation/differentiation (Fig. 10F), similar
to when a dominant negative FGFR1 was overexpressed to block
FGFR-signaling (Fig. 10D).
3.5. Lens epithelial cell proliferation
Whilst impaired ﬁber cell differentiation may contribute to the
smaller lens size in Spry1GOF and Spry2GOF mice, we examined
other cellular processes required for lens growth, including lens
epithelial cell proliferation. We ﬁrst compared the number of lens
epithelial cells in sequential mid-sagittal lens sections from WT,
Spry1GOF and Spry2GOF mice (Fig. 11A). Compared to the WT lens
epithelium at different postnatal stages (P2, P4, and P9), the size oftransgenic mice lens, at P0 (A–F), P5 (G–M) and P10 (N–S). When the anterior lens
e compared to that of WT (A, G, N), the Spry1GOF lens capsule appeared similar in
ifferent (Spry1GOF lens, 3.970.3 mm;WT lens, 3.670.4 mm). The anterior capsule of
8; po0.0003) than that of the WT lens (N) at P10. The posterior lens capsule (right
mice lens were of similar thickness at P0; however, at P5, the posterior capsule of
osterior capsules of Spry1GOF and Spry2GOF lenses ruptured (Q, S). Scale bar, 30 mm.
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smaller for all ages of Spry1GOF and Spry2GOF mice (student's t-
test; po0.0005). In WT mice, cell numbers increased in number
from 143 (P2) to 193 (P4) to 200 (P9), compared to similar in-
creases, albeit reduced cell numbers, for both Spry1GOF (127, 161,
and 186) and Spry2GOF (97, 125, and 128) mice, respectively
(Fig. 11A). This reduced cell number was not a result of increased
cell death/apoptosis (as determined by the absence of any cleaved-caspase-3-labeling; data not shown), but by a reduced rate of
epithelial cell proliferation. The percentage of BrdU-labeled cells in
the WT, Spry1GOF and Spry2GOF P2 lens was progressively lower
(21.9%, 20.4% and 18.5%, respectively, Fig. 11B), with the greatest
and most signiﬁcant difference in proliferation rate between the
WT and Spry2GOF lens (Kruskal–Wallis test; po0.005). The rate of
epithelial cell proliferation in the whole epithelium of the
Spry1GOF lens was not signiﬁcantly different to that of the WT lens
(Kruskal–Wallis test; p40.05); however, if we compared the
central and peripheral regions of the epithelium, there were
marked differences between the Spry1GOF and WT lens (Fig. 11C).
The rate of proliferation in the central epithelium of the Spry1GOF
lens (12.1%) was signiﬁcantly lower than that of the WT central
lens epithelium (19.4%; Kruskal–Wallis test; po0.005). In con-
trast, the proliferation rates of the peripheral epithelium of the WT
lens (25.1%) and Spry1GOF lens (27.7%), did not markedly differ
(Fig. 11C). The combination of the data of the central and periph-
eral epithelial cell proliferation rates results in the previously ob-
served insigniﬁcant difference in total epithelial cell proliferation
rate between the WT lens and Spry1GOF lens. For completeness,
the central and peripheral lens epithelium of WT and Spry2GOF
were also compared, with a signiﬁcant decrease only observed
between their peripheral epithelia (19.4% and 11.9%; Kruskal–
Wallis test; po0.005) and not their central epithelia (25.1% and
23.6%, respectively; data not shown).
It should be noted that the lens epithelial cell phenotype in the
Spry2GOF lens was speciﬁcally due to overexpression of Spry in the
lens epithelia and not extra-lenticular overexpression. When we
characterized alternate Spry2GOF lines with Spry2 overexpressed
speciﬁcally to the lens cells (using a different Cre-transgenic line;
MLR10-Cre), we saw no signiﬁcant difference at E15.5 in lens
epithelial cell number or rate of cell proliferation relative to age-
matched WT lens (data not shown).3.6. Rate of lens ﬁber cell differentiation
To determine the rate of lens epithelial cell differentiation into
ﬁbers, BrdU-labeled cells were traced for 7 days at P9, after BrdU
incorporation at age P2. This study has the underlying principle
that BrdU-incorporation in nuclei of proliferating lens epithelial
cells will persist as they or their progenitors are displaced into the
lens cortex as they exit the cell cycle and differentiate into sec-
ondary ﬁber cells (Fig. 12). In the WT, Spry1GOF and Spry2GOF lens
ﬁber cortex sections, an average of 23, 21 and 11 BrdU-labeled cells
were detected after 7 days, respectively (Fig. 12D). Compared to
the WT lens (Fig. 12A and D), the number of BrdU-labeled cells in
the lens cortex sections of the Spry2GOF lens (Fig. 12C and D) was
signiﬁcantly reduced (student's t-test; po0.0005), while the
Spry1GOF transgenic lens sections showed no signiﬁcant difference
in labeled cell number (Fig. 12B and D).Fig. 6. (A–D). PAS staining of sections of P10 rat lens epithelial explants treated
without FGF2 (A, B) or with 100 ng/ml FGF2 (C, D) in the presence (B, D) or absence
(DMSO-treated, A, C) or LY294002 (selective PI3K inhibitor) over 5 days. In the
presence of FGF2 treatment or not, after 5 days culture, lens explants formed a new
layer of lens capsule ECM (arrow) at the cell/capsule junction (A, C). With the
addition of LY294002; however, this ECM failed to form, with the resultant lens
capsule signiﬁcantly thinner, irrespective of FGF stimulation (B, D; student's t-test:
ControlþLY294002, po0.0001; FGFþLY294002, po0.0001). Scale bar, 5 mm.
(E) Representative western blots of pAkt (upper panel), total Akt (middle panel)
and GAPDH (loading control; lower panel) from P7, WT mice, and Spry1GOF and
Spry2GOF transgenic mice, showed that levels of pAkt appeared lower in the
transgenic lenses, however, relative to total Akt and GAPDH levels, the pAkt levels
between genotypes was not signiﬁcant (F; student's t-test: Spry1GOF p40.1;
Spry2GOF p40.4. Error bars represent standard errors).
Fig. 7. Representative micrographs of β-crystallin labeling in the lenses of neonatal (P0) WT mice, and Spry1GOF and Spry2GOF transgenic mice. Parafﬁn sections of WT lens
(A, B), and Spry1GOF (C, D) and Spry2GOF (E, F) transgenic lenses were labeled for β-crystallin protein (B, D, and F) and cell nuclei counterstained with Hoechst dye (A, C, and
E). All mice lines showed relatively normal patterns of β-crystallin labeling in lens ﬁber cells. Scale bar, 100 mm.
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The endogenous levels of phosphorylated ERK1/2 and total
ERK1/2 in P21, WT mice lens, and age-matched Spry1GOF and
Spry2GOF transgenic mice lens were assayed using western blot-
ting (Fig. 13). The representative western blots showed that
Spry1GOF and Spry2GOF lens have lower levels of pERK1/2, com-
pared to that of the WT lens (Fig. 13A). Quantitative analysis of the
western blots showed that when the ratio of pERK1/2 to total
ERK1/2 in the WT lens was standardized to a value of 1, the re-
lative levels of pERK1/2 in the transgenic lenses were signiﬁcantly
lower (student's t-test; po0.0005), recorded as 0.35 and 0.71 for
Spry1GOF and Spry2GOF lenses, respectively (Fig. 13B). Given that
the total ERK1/2 levels across the different genotypes was not
equal, we used GAPDH levels to standardize the western blots
against the total ERK1/2 levels. The cells of the Spry1GOF and
Spry2GOF transgenic lenses were shown to express signiﬁcantly
higher levels of total ERK1/2, than those of the WT lens (student's
t-test; Spry1GOF po0.0005; Spry2GOF po0.005), recorded as 1.47
and 1.15 for Spry1GOF and Spry2GOF lenses, respectively (Fig. 13C).
Thus, when the pERK1/2, total ERK1/2 and GAPDH levels are
considered together, it appears that the Spry1GOF and Spry2GOF
transgenic mice lens cells have higher levels of total ERK1/2, but
the levels of phosphorylated ERK1/2 are lower when compared to
the WT lens cells. Immunoﬂuorescence on neonatal WT, Spry1GOF
and Spry2GOF transgenic mice lenses show a consistent decrease in
label of pERK1/2 in Spry1GOF and Spry2GOF mice (data not shown).
We demonstrate above that lens-speciﬁc overexpression of
Spry1 or Spry2 in situ resulted in a decreased pool of phos-
phorylated ERK1/2 and an increased level of total ERK1/2 in the
lens. To determine the ability of these same cells to phosphorylateERK1/2 in response to exogenous factors in vitro, we prepared lens
epithelial explants from postnatal-day-7 WT, Spry1GOF and
Spry2GOF mice and determined the responsiveness of cells to dif-
ferent doses of FGF2 (Fig. 14) and EGF (Fig. 15) for up to 20 min.
With no growth factor addition, the central epithelial cells of the
WT lens, and Spry1GOF and Spry2GOF transgenic lenses all had very
similar low basal pERK1/2 labeling (Figs. 14A–C and 15A–C). With
a relatively low (5 ng/ml) proliferating dose of FGF2, some isolated
epithelial cells of the WT lens, and Spry1GOF and Spry2GOF lenses
expressed higher levels of pERK1/2 (Fig. 14D–F, arrows). The pERK
levels; however, appeared higher in cells of the WT lens explants.
When the dose of FGF-2 was increased (50 ng/ml), the greatest
difference in ERK1/2 phosphorylation was now observed between
the WT and transgenic lens explants with ERK1/2 phosphorylation
homogenously observed across the entire WT lens explant
(Fig. 14G). The explants of the Spry1GOF and Spry2GOF lenses
(Fig. 14H and I) showed increased pERK labeling, albeit at mark-
edly lower levels compared to the WT lens explants. Moreover,
labeling for pERK in the transgenic lens epithelial cells was not
homogenous across the explants, with select cells demonstrating
higher pERK1/2 levels. With an even higher (100 ng/ml), differ-
entiating dose of FGF2, there was saturation of ERK1/2 phos-
phorylation in the WT lens explants, with all epithelial cells de-
monstrating high pERK1/2 levels (Fig. 14J). The Spry1GOF and
Spry2GOF lens explants also showed high levels of ERK1/2 phos-
phorylation (Fig. 15K and L), closely resembling the WT lens
pERK1/2 levels; however, there were isolated cells that demon-
strated little to no pERK1/2 labeling (Fig. 14K and L, arrowheads).
Experiments with EGF demonstrated a similar result to that
seen with FGF. With 50 ng/ml of EGF, isolated central epithelial
cells of the WT lens showed markedly elevated phosphorylation of
Fig. 8. Representative micrographs of lens epithelial explants from P7, WT mice (A–D), or Spry1GOF (E–H) and Spry2GOF (J–M) transgenic mice lenses, treated with 100 ng/ml
of FGF2 (right hand panels) or without (left hand panels) for either 5 days (C, D, G, H, L, and M) or 10 days (A, B, E, F, J, and K). Tissues were stained for lectin (A, B, E, F, J, and
K, purple), β-crystallin (D, H, and M, green) and counterstained with propidium iodide (C, G, and L, red). The lectin stain outlines cell membranes, highlighting organelles and
cell shape changes. In response to FGF2, WT lens epithelial cells underwent elongation (B) and accumulated β-crystallin (D). Epithelial cells of the Spry1GOF lens explants also
elongated (F) with FGF2 treatment (D) with little β-crystallin accumulation by 5 days (H). In contrast, in Spry2GOF transgenic mice lens explants, cells showed little to no
differentiation (K) in response to FGF2, with no β-crystallin detected (M). Scale bar, 10 mm.
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explants, under the same treatment conditions, also demonstrated
an increased ERK1/2 phosphorylation (Fig. 15E and F); however,
much lower than that of the WT cells. At higher doses (100 ng/ml)
of EGF, a greater number of epithelial cells responded, with ERK1/2
phosphorylation increasing in all lens explants (Fig. 15G–I); how-
ever, the levels of ERK1/2 phosphorylation in the epithelial cells of
both Spry1GOF and Spry2GOF transgenic lenses was still lower thanthat of the WT lens. Overall, lens epithelial cells of the Spry1GOF
and Spry2GOF transgenic mice demonstrated a reduced ability to
phosphorylate ERK1/2 in response to FGF2 and EGF. The FGF2- or
EGF-induced phosphorylation of ERK1/2 was dose-dependent,
with intermediate (50 ng/ml) doses of both FGF-2 and EGF
showing the greatest differences between lenses of WT and the
SpryGOF mice. Interestingly, this in vitro assay also demonstrated
that FGF-2 stimulation results in a more homogenous ERK1/2
Fig. 9. Representative micrographs of neonatal rat lens epithelial cells transfected
with pLXSG (A, B), pLXSG-Spry1 (C, D) or pLXSG-Spry2 (E, F), and treated with
(right panels) or without (left panels) a differentiating dose (100 ng/ml) of FGF2 for
5 days. All successfully transfected cells ﬂuoresce green for the EGFP reporter. The
control lens epithelial cells transfected with either pLXSG, or overexpressing Spry1
(pLXSG-Spry1) or Spry2 (pLXSG-Spry2) with no growth factor treatment remained
cuboidal in shape (A, C, and E). With FGF2 treatment, lens epithelial cells trans-
fected with the control pLXSG plasmid changed their morphology and began to
elongate. A subpopulation of the lens epithelial cells transfected with pLXSG-Spry1
or pLXSG-Spry2, however, did not elongate (D, F, arrows). Scale bar, 100 mm.
(G) Quantitative analysis of the percentage of the FGF2-induced lens epithelial cell
elongation showed that with FGF2 treatment, there were 63.7%, 31.9% and 32.9%
elongation among the cells transfected with pLXSG, pLXSG-Spry1 and pLXSG-
Spry2, respectively. Spry1 or Spry2 overexpression in lens epithelial cells in vitro,
demonstrated a signiﬁcant reduction in FGF2-induced cell elongation (n¼5, Stu-
dent's t-test; po0.005).
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EGF-induced ERK1/2 phosphorylation was limited to a subset of
the lens explant cell population.
It should be noted that while the higher expression levels of
Spry1 in the LOV28 transgenic line resulted in a prominent phe-
notype, the other characterized Spry1 lines presented a similar
phenotype (data not shown), with microphthalmia and smaller
lenses, and a similar reduction in height of lens epithelia and re-
duced thickness of lens capsule, validating the speciﬁcity of the
effect of Spry1 overexpression.4. Discussion
In the present study we demonstrate an important inhibitory
role for Spry in the regulation of lens cell proliferation and ﬁber
differentiation in situ, potentially through its ability to modulate
FGF- and even EGF-mediated MAPK/ERK1/2 signaling in lens cells.
Overexpression of Spry in the lens epithelial and ﬁber cells re-
sulted in reduced lens size during ocular morphogenesis, inﬂu-
enced by changes to the lens epithelium, aberrant ﬁber cell dif-
ferentiation and compromised de novo maintenance of the lens
capsule. Given the fact that Spry is normally highly expressed
throughout lens morphogenesis in both differentiating lens epi-
thelium and primary ﬁber cells, with reduced expression in ﬁbers
during fetal and postnatal growth (see Boros et al. (2006)), it is not
surprising that overexpression of Spry1 or Spry2 in lens in the
present study has a marked impact on lens differentiation later in
its development and growth.
4.1. Spry negatively regulates lens epithelial cell proliferation
Overexpression of Spry in the lens epithelium led to pronounced
changes such as progressively reduced cell numbers and some
thinning of the epithelium, similar to that seen in lenses of mice
deﬁcient for a known Sprouty target, MAPK1/ERK2 (Upadhya et al.,
2013). Earlier conditional deletion studies of both Spry1 and Spry2 in
the developing lens do not report any changes to lens epithelial cell
proliferation at E15.5 (Kuracha et al., 2011), most likely owing to the
fact that there are other negative regulators, including members of
the Spred family co-expressed in the lens (Zhao et al., 2015) that
may compensate for this loss of Sprouty at this time. In contrast, in
the present study with Spry1GOF and Spry2GOF transgenic mice
lenses, there was a signiﬁcant reduction in epithelial cell prolifera-
tion when Spry was overexpressed. In the Spry1GOF lens, this was
most evident in the central lens epithelium. This reduced epithelial
cell proliferation correlated with the reduced number of lens epi-
thelial cells in both the Spry1GOF and Spry2GOF transgenic mice,
compared to that of WT mice. This is consistent with the reported
role of Spry1, Spry2 and even Spry4 as anti-proliferative regulators
of serum or growth factor- (EGF, FGF, PDGF, VEGF, and HGF) induced
DNA synthesis/cell proliferation (Edwin et al., 2006; Gross et al.,
2001; Lee et al., 2004, 2001; Yigzaw et al., 2001). In human umbilical
vein endothelial cells, it is suggested that Spry induces cell cycle
arrest and not cell death (Lee et al., 2001), consistent with our ob-
servations. hSpry2 overexpression in SK-LMS-1 human leiomyo-
sarcoma cells also resulted in cell cycle arrest at the G2/M phase (Lee
et al., 2004), suggesting Spry2 prevents cells from re-entering the G1
phase. Moreover, ectopic hSpry2 expression can decrease cell cycle
progression from the G1 to S phase (Edwin et al., 2006), consistent
with an elevation in the expression and activity of PTEN (phospha-
tase and tensin homolog deleted on chromosome 10). PTEN has
been shown to cause cell cycle arrest in the G1 phase (Li and Sun,
1998) and is known to suppress PI3K/Akt-signaling (Cantley and
Neel, 1999). Taken together with Spry's reported inability to inhibit
proliferation and suppress PI3K/Akt-signaling in PTEN-deﬁcient cells
Fig. 10. Representative micrograph of lens explants transfected with pLXSG (A, B), pLXSG-dnFGFR (C, D), pLXSG-Spry2 (E, F) or pLXSG-ΔSpry2 (G, H), cultured without FGF2
(A, C, E, and G), or with 100 ng/ml of FGF2 (B, D, F, and H) for 5 days. In the presence of FGF, cells over-expressing pLXSG (B,) or pLXSG-ΔSpry2 (H) elongated. Cells
overexpressing pLXSG-dnFGFR (D) or pLXSG-Spry2 (F) did not elongate/differentiate with FGF2. Scale bar, 100 μm.
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ulation of cell cycle progression partially through the actions of
PTEN, and regulation of Akt phosphorylation. Whilst we observed
slightly lower, albeit not signiﬁcant levels of pAkt in whole postnatal
SpryGOF transgenic mice lenses, we can not rule out reduced levels of
pAkt speciﬁcally in the lens epithelia, hence a role for PI3K-signaling
in cell proliferation, consistent with our earlier studies (Iyengar et al.,
2006). This is supported by hSpry2's ability to decrease EGF- or
serum-induced Akt phosphorylation (Edwin et al., 2006). As other
studies in different cell types have shown that Spry does not affect
the PI3K/Akt pathway (Gross et al., 2001; Yusoff et al., 2002), Sprys'
negative regulation of ERK1/2 signaling may play a more signiﬁcant
role in suppressing lens cell proliferation in our in vivo study, con-
sistent with other in situ studies in lenses deﬁcient for MAPK1
(Upadhya et al., 2013), as well as our previous in vitro studies using
MEK1 inhibition (Iyengar et al., 2006, 2009). Our future studies are
aimed to develop more effective means of speciﬁcally identifying the
direct targets of Sprouty activity in lens cells.4.2. Spry negatively regulates lens ﬁber cell differentiation
Our in vivo observations demonstrate that overexpression of
either Spry1 or Spry2 in the lens results in a ‘small’ lens pheno-
type. While this may be a compound phenotype resulting from
reduced cell numbers as discussed earlier, it is evident that this
smaller lens may also result from compromised lens ﬁber cell
differentiation, resulting in shorter, yet still elongate ﬁber cells. We
should note that the primary ﬁber cell phenotype is directly due to
overexpression of Sprouty in situ, and not a secondary effect re-
lating to changes in the lens epithelium, given that at earlier
neonatal stages when we see a ﬁber cell phenotype, the lens
epithelial cells appear relatively normal. Moreover, in SpryGOF
mice, in particular the Spry2GOF mice, the rate of epithelial cells
differentiating into ﬁbers is markedly reduced and when epithelial
cells do manage to differentiate into ﬁbers, the ﬁber cell nuclei are
poorly arranged compared to WT lens, with ﬁbers cells appearing
disorganized and vacuolated, comparable to lenses of mice
E.H. Shin et al. / Developmental Biology 406 (2015) 129–146 141deﬁcient for ERK2 (Upadhya et al., 2013). Interestingly these ﬁber
cells still express ß- and γ-crystallins; however, we should be
mindful that expression of these molecular markers of ﬁber dif-
ferentiation have been show not to be dependent on ERK1/2 sig-
naling (see Lovicu and McAvoy 2001; Wang et al., 2010; Upadhya
et al., 2013), which appears to be the likely target of Sprouty in
these trangenic lenses resulting in the morphologic phenotype.
Sprouty's ability to negatively regulate ﬁber differentiation
in situ is further supported by our in vitro evidence using lens
epithelial cell explants from transgenic mice overexpressing Spry1
or Spry2; their compromised ability to respond to differentiation-
stimuli (such as FGF2). This was independently supported by fur-
ther in vitro experiments, whereby ectopic overexpression of
Spry1 or Spry2 in rat lens epithelial cells was sufﬁcient to block asigniﬁcant subpopulation of epithelial cells from undergoing FGF2-
induced ﬁber cell differentiation. This ability of both Spry1 or
Spry2 to impede FGF2-induced activity in lens was also similarly
observed in PC12 cells (Gross et al., 2001). Murine Spry1 and Spry2
overexpression in PC12 cells resulted in reduced FGF- or NGF-in-
duced cell differentiation, with the cells developing shorter and
reduced branching of neurites (Gross et al., 2001). We should note
that not all lens cells overexpressing Spry1 or Spry2 were able to
completely block lens ﬁber differentiation in vitro, consistent with
the presence of relatively normal lens ﬁber cells in the Spry1GOF
and Spry2GOF transgenic mice. This clearly indicates that the
suppressive effects of Spry may be dose-dependent, consistent
with the fact that mice hemizygous for Spry1 gain of function
(Shin et al., 2012) develop a relatively normal lens compared to the
homozygous lines reported here. Sprouty gene dosage has also
recently been reported to be required for temporal-spatial super-
numerary tooth formation (Lochovska et al., 2015).
Whilst Spry overexpression has the potential to impair lens
ﬁber differentiation, it may also inﬂuence the rate of epithelial
cell-to-ﬁber differentiation, as we report here. By tagging pro-
liferative lens epithelial cell nuclei in situ following BrdU-in-
corporation, and monitoring the fate of these cells after a deﬁned
period, we noted that the number of Spry2GOF lens epithelial cells
entering the lens cortex and subsequently differentiating, were
fewer in number resulting in the fewer secondary ﬁbers in the lens
cortex compared to the lens of WT or Spry1-overexpressing mice,
similar to that seen in lenses of mice deﬁcient for ERK2 (Upadhya
et al., 2013). This was not necessarily a reﬂection of reduced epi-
thelial cell numbers in transgenic mice to start with, as a similar
percentage of epithelial cells were BrdU-labeled at the lens per-
iphery in all groups of animals examined. Whether this ﬁber dif-
ferentiation process is delayed or is a consequence of impaired cell
migration is not clear and merits further investigation. Indeed in
other studies in rat intestinal epithelia (IEC-6 cells), Spry2 in-
hibited migratory activity by inhibiting Rac1 activation (Poppleton
et al., 2004). Rac1 GTPase activity clearly has been shown to play
an essential role not only in lens ﬁber cell migration (Maddala
et al., 2011) but also ECM turnover (see later Section 4).
Interestingly, a slight increase in the proliferation rate of per-
ipheral lens epithelial cells, coupled with a slightly decreased rate
of ﬁber cell differentiation in the Spry1GOF lens, compared to theFig. 11. (A) Quantitative analysis of the total number of epithelial cells in sections
of WT lens, and Spry1GOF and Spry2GOF transgenic lenses at P2, P4 and P9. The
average number of epithelial cells in a section of WT lens were 143, 193 and 200 for
ages P2, P4 and P9, respectively. The average number of epithelial cells in sections
of Spry1GOF transgenic mice lens were 127, 161 and 186 for ages P2, P4 and P9,
respectively. The average number of epithelial cells in sections of Spry2GOF trans-
genic mice lens were 97, 125 and 128 for ages P2, P4 and P9, respectively. At P2, the
size of the lens epithelium of both Spry1GOF and Spry2GOF transgenic lines was
signiﬁcantly smaller than the WT lens epithelium size (Student's t-test;
po0.0005). This trend was also observed at P4 (Student's t-test; po0.0005) and
P9 (Student's t-test; po0.0005). Error bars represent standard errors.
(B) Quantitative analysis of the percentage of BrdU-incorporation in lens epithelial
cells of WT mice, and Spry1GOF and Spry2GOF transgenic mice at P2. Blind counts
showed 21.9%, 20.4% and 18.5% of epithelial cells labeled for BrdU in WT, Spry1GOF
and Spry2GOF lenses, respectively. The proliferation rate of Spry2GOF transgenic lens
epithelial cells was signiﬁcantly lower than that of WT lens (Kruskal–Wallis test
T¼12.76; n¼54; p¼0.0018). The proliferation rate of Spry1GOF transgenic lens
epithelial cells showed no signiﬁcant difference compared to that of WT lens
(Kruskal–Wallis test T¼12.76; n¼54; p¼0.1684). Error bars represent standard
errors. (C) Quantitative analysis of the percentage of BrdU-incorporation in the
more central anterior and peripheral lens epithelial cells of WT lens and Spry1GOF
transgenic lens. For the central lens epithelium, cell proliferation rates were 19.4%
and 12.1% for the WT lens and Spry1GOF lens, respectively, signiﬁcantly lower in the
Spry1GOF transgenic lens (Kruskal–Wallis test T¼13.96; n¼54; p¼0.001). For the
peripheral lens epithelium, the cell proliferation rates were 25.1% and 27.7% for the
WT lens and Spry1GOF lens, respectively, with no signiﬁcant difference in rate of
proliferation (Kruskal–Wallis test T¼5.35; n¼54; p¼0.337). Error bars represent
standard errors.
Fig. 12. Representative micrographs of montages of BrdU-labeled lens cells in P9, WT mice lens (A), and Spry1GOF (B) and Spry2GOF (C) transgenic mice lenses tracked after
7 days post injection. BrdU was injected at P2, and the tissue was collected after 7 days. Seven days following BrdU injection, an average of 23, 21 and 11 BrdU-labeled
epithelial cells migrated into the lens ﬁber cortex in the WT, Spry1GOF and Spry2GOF lens, respectively (A–D). Scale bar, 100 mm. (ii) Quantitative analysis of these BrdU-
labeled cells that migrated into lens cortex showed that rate of new secondary ﬁber differentiation in the Spry2GOF transgenic lens was signiﬁcantly lower than that of the
WT lens (Student's t-test; n¼18; po0.0005); however, no signiﬁcant difference was seen in the Spry1GOF transgenic lens when compared to that of the WT lens (Student's t-
test; n¼18; p40.1). Error bars represent standard errors.
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posterior to the lens equator. More lens epithelial cells were mi-
totic in the Spry1GOF lens, and less of their progeny were exiting
the cell cycle to become lens ﬁbers. In addition, the size of the
Spry1GOF lens was smaller compared to the WT lens due to in-
sufﬁcient numbers of ﬁbers, and perturbed elongation of these
cells.
Overall, Spry1 and Spry2 were able to inhibit/impair both lens
cell proliferation and ﬁber differentiation, which share some si-
milar signaling pathways and regulators (see Lovicu and McAvoy,
2001; Iyengar et al., 2007). This inhibitory effect of Spry and the
resultant cell fate may also depend on the cellular context. For
example in human leiomyosarcoma cells, cell movement is re-
stricted by hSpry2 by facilitating cell attachment and spreading
through enhancement of focal adhesions (in particular vinculin)
and increased expression of stress ﬁbers (in particular F-actin; Lee
et al. (2004)). This promotion of cell spreading, coupled with the
decreased central lens epithelial cell proliferation rate, may in part
also account for the thinner lens epithelium observed in our
Spry2GOF transgenic lines.
4.3. Spry negatively regulates FGF- and EGF-induced ERK1/2
signaling
Whilst there may be several contributing factors accounting for
the reduced size of the lens in the Spry1GOF and Spry2GOF trans-
genic mice, in order to understand the molecular mechanismsleading to the Spry-mediated suppression of lens epithelial cell
proliferation and differentiation, we examined one of its direct
targets, ERK1/2 signaling. In situ overexpression of Spry in trans-
genic mice lenses, led to a reduction in endogenous ERK1/2
phosphorylation in both the lens epithelial and ﬁber cells of the
Spry1GOF and Spry2GOF transgenic mice. Not surprisingly, as
mentioned earlier, the postnatal lens phenotype we report here, in
particular that seen in Spry2GOF transgenic mice, is very similar to
recent reports of the phenotype of postnatal lenses deﬁcient for
MAPK1/ERK2 (Upadhya et al., 2013). Moreover, in our in vitro
studies we demonstrated that these lens epithelial cells over-
expressing Spry1 or Spry2 have a reduced ability to phosphorylate
ERK1/2 in response to either FGF and EGF, and this was dose-de-
pendent. Overexpression of Spry has been previously demon-
strated to mimic the functional loss of RTKs (Casci et al., 1999),
with Spry proteins established as negative regulators of FGF- and
EGF-induced ERK/MAPK activation (Casci et al., 1999; Hacohen
et al., 1998; Kramer et al., 1999), interfering at the level of FRS2,
Shp2, Grb2, C-Raf and B-Raf (Cabrita and Christofori, 2008; Guy
et al., 2009, 2003; Kim and Bar-Sagi, 2004; Mason et al., 2006).
Contrary to this, Spry may even potentiate EGF-induced ERK/
MAPK activation (via reduced EGFR ubiquitination) in certain
cellular contexts, whereas it consistently negatively regulates FGF-
induced ERK/MAPK signaling (Impagnatiello et al., 2001; Sasaki
et al., 2001). Our results of negative regulation of FGF-induced
ERK/MAPK signaling by Spry1 or Spry2 were consistent with other
studies (Glienke et al., 2000; Gross et al., 2001; Tefft et al., 2002)
Fig. 13. Endogenous levels of phosphorylated ERK1/2 relative to total ERK1/2 in
lysates of WT lens, and Spry1GOF and Spry2GOF transgenic mice lenses at P21.
(A) Representative western blot of the lysates of WT lens, and Spry1GOF and
Spry2GOF transgenic mice lenses for levels of phosphorylated ERK1/2 (pERK1/2;
upper panel), total ERK1/2 (tERK1/2; middle panel) and GAPDH (loading control;
lower panel). The pERK1/2 levels in the Spry1GOF and Spry2GOF transgenic lenses
appeared lower than that of the WT, with total ERK1/2 levels in the Spry1GOF and
Spry2GOF transgenic lenses appearing slightly higher than that of the WT. GAPDH
levels were constant for the 3 genotypes. (B) Quantitative analysis of pERK1/2 le-
vels (relative to total ERK1/2), set to a value of 1 for WT, showed pERK1/2 levels in
Spry1GOF and Spry2GOF lenses to be 0.35 and 0.71, respectively, both signiﬁcantly
lower than that of the WT lens (Student's t-test; po0.0005). Error bars represent
standard errors. (C) Quantitative analysis of total ERK1/2 levels (relative to GAPDH
levels), set to a value of 1 for WT, showed that both Spry1GOF and Spry2GOF
transgenic lenses had higher basal levels of total ERK1/2, compared to that of WT
lens, measuring 1.47 and 1.15, respectively. These ratios were signiﬁcantly higher
than that of WT lens (Student's t-test; Spry1GOF po0.0005; Spry2GOF po0.005).
Error bars represent standard errors.
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potentiation of EGF-induced ERK/MAPK signaling in lens epithelial
cells, which merits further investigation. Interestingly, we noted a
heterogeneity in the responsiveness of lens epithelial cells in lens
explants to FGF and EGF in vitro, and this may also be the case
in situ. Lens epithelial cells are known to be comprised of a het-
erogenous population, most notably the normally quiescent
anterior central epithelial cells compared to the more mitotically-
active peripheral cells of the germinative zone (Zhou et al., 2006).
This heterogeneity between the different epithelial cells may re-
side on a number of different factors, including differential high
afﬁnity receptor distribution (de Iongh et al., 1997; Collison and
Duncan, 2001), and in the case of our present study, possibly dif-
ferential levels of Sprouty overexpression in different epithelial
cells, with some cells more or less resistant to growth factor-in-
duced ERK1/2-phosphorylation. Further studies in vitro in lens,
with more tighter control of Sprouty mis-expression are war-
ranted to better examine the mode of Sprouty activity.
Whilst it has been proposed that hSpry2 has a greater in-
hibitory potency on the Ras/MAPK signaling pathway than mSpry1
or mSpry4 (Yusoff et al., 2002), possibly accounting for the more
severe lens phenotype in our Spry2GOF lines, this is difﬁcult to
compare in our present models given the different modes of
Sprouty delivery. Both Spry1 and Spry2 are effective at blocking
FGF-induced lens ﬁber differentiation and concomitant phos-
phorylation of ERK1/2 phosphorylation in vitro, yet they present
distinct but overlapping phenotypes when each is speciﬁcally
deleted from the postnatal murine lens (see Shin et al. (2012)).
4.4. Spry modiﬁes extracellular matrix
The lens capsule is the continuous basement membrane that is
secreted by lens cells (Tholozan and Quinlan, 2007). The anterior
and posterior surfaces of the lens capsule differ in thickness,
composition and architecture (Johnson and Beebe, 1984; Cam-
marata and Spiro, 1985; Cammarata et al., 1986). The hetero-
geneity observed between various regions of the lens capsule may
be due to the differential production, deposition or modiﬁcation of
the ECM by the lens cells themselves. Additionally, this may be due
to ECM degrading enzymes, namely, the matrix metalloprotei-
nases (MMPs), soluble in the aqueous and vitreous humors (Brown
et al., 1994; Huang et al., 1996; De La Paz et al., 1998). We observed
posterior lens capsule thinning in both the Spry1GOF and Spry2GOF
transgenic lines, ultimately resulting in posterior lens capsule
rupture and extrusion of lens ﬁbers into the vitreous chamber. The
modiﬁcation of the anterior lens capsule of the Spry1GOF or
Spry2GOF transgenic lines, compared to the WT, was dissimilar to
each other. For the Spry1GOF transgenic lens, the anterior capsule
appeared to thicken at the time of posterior capsule rupture, and
this persisted through to older ages. For the Spry2GOF transgenic
lens, the anterior lens capsule remained thinner than that ob-
served in the WT lens of equivalent age. Due to this inconsistency
in the anterior lens capsule of the two transgenic lines, given that
this may have been a secondary effect of the thinning and sub-
sequent ruptured posterior lens capsule, we focused primarily on
the posterior capsule phenotype.
We examined PI3K/Akt signaling as a potential pathway mod-
iﬁed by Spry to regulate ECM synthesis. The Akt signaling pathway
has been shown to positively regulate basement membrane for-
mation, in particular certain laminin and type IV collagen isotypes,
upon RTK activation (Li et al., 2001a, b). Furthermore, FGF2 can
upregulate α1(I) collagen transcription through PI3K signaling (Ko
and Kay, 2005). We noted in lens explants stimulated with FGF
that if we block PI3K/Akt signaling (using the LY294002 inhibitor),
there is reduced de novo lens capsular ECM material synthesis
compared to explants treated without LY294002. Prior to posterior
Fig. 14. Representative micrographs of phosphorylated ERK1/2 in epithelial explants of WT mice lens, and Spry1GOF and Spry2GOF transgenic mice lenses at P7, following a
treatment to increasing doses of FGF2. Explants were labeled for pERK1/2 (green), and nuclei counterstained with propidium iodide (red). WT lens (A, D, G, and J) and
Spry1GOF (B, E, H, and K) and Spry2GOF (C, F, I, and L) transgenic lenses were explanted. The explants were treated for 20 min with 5 ng/ml FGF2 (D, E, and F), 50 ng/ml FGF2
(G, H, and I), 100 ng/ml FGF2 (J, K, and L), or with no FGF (control; A, B, and C). With no growth factor treatment, the basal levels of pERK1/2 expression in the central
epithelial cells of WT lens, and Spry1GOF and Spry2GOF transgenic lenses were very low and similar to each other (A–C). Treatment with 5 ng/ml FGF2 resulted in slight
increase in pERK1/2 level in some isolated central epithelial cells of the WT, Spry1GOF and Spry2GOF lens explants (D–F, arrows). With 50 ng/ml FGF2 treatment, the central
lens epithelial cells of the WT mice showed homogenously higher pERK1/2 labeling (G), while the Spry1GOF and Spry2GOF transgenic lens explant cells had markedly lower
pERK1/2 levels (H, I) to that seen in WT lens (G). With 100 ng/ml FGF2; however, the Spry1GOF and Spry2GOF transgenic lens explant cells, displayed similar widespread
pERK1/2 levels to that of the WT lens explant cells, with some isolated cells in the Spry1GOF and Spry2GOF transgenic lens explants failing to label strongly for pERK1/2 (K, L,
arrowheads). Scale bar, 10 mm.
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of Akt, albeit not signiﬁcant, in the Spry1GOF or Spry2GOF trans-
genic lenses. Taken together, it is feasible that Spry-mediated ne-
gative regulation of PI3K/Akt signaling may lead to a reduction of
ECM that normally contributes to posterior lens capsule thicken-
ing. However, we can not rule out that the capsule thinning was
due to an increase in ECM degradation, or a combination of both.
MMPs have the ability to degrade and remodel ECM compo-
nents (Massova et al., 1998; Huang et al., 1996). MMP-2 and MMP-
9 belong to the gelatinase subfamily of MMPs and are known to
preferentially digest native collagens (types IV, V and VII), dena-
tured collagens (types I, II and III), and certain proteoglycans and
glycoproteins (Brown et al., 1994). Using lens culture, gelatin zy-
mography and immunoﬂuorescence, we were not able to detect
any signiﬁcant differences in MMP-2 or MMP-9 between the WT
lens and the transgenic lens epithelial cells overexpressing Spry1or Spry2 (data not shown). Aqueous and vitreous humors also
contain MMPs (Brown et al., 1994; De La Paz et al., 1998; Huang
et al., 1996), with MMP-9 increasing dramatically in the humor
(Huang et al., 1996; Brown et al., 1994; Kosano et al., 1999) of
patients with proliferative diabetic retinopathy, or following cat-
aract surgery. As noted earlier, given that Rac1 GTPase activity has
been shown to play an essential role in lens ECM turnover (Mad-
dala et al., 2011) and Spry2 can limit Rac1 activation (Poppleton
et al., 2004), this may be the contributing mechanism to the lens
capsule rupture. It would be interesting to identify other Spry
targets that inﬂuence ECM breakdown or remodeling.
In summary, we have shown Spry to play an important in-
hibitory role in the regulation of lens cell proliferation and dif-
ferentiation, potentially interfering with the FGF- and EGF-medi-
ated MAPK/ERK1/2 signaling pathway. This primarily resulted in
aberrant lens development and impaired growth of the eye,
Fig. 15. Representative micrographs of phosphorylated ERK1/2 in explants of WT mice lens, and Spry1GOF and Spry2GOF transgenic mice lenses at P7, following treatment
with different doses of EGF. Explants were labeled for pERK1/2 (green), and nuclei counterstained with propidium iodide (red). WT lens (A, D, and G) and Spry1GOF (B, E, and
H) and Spry2GOF (C, F, and I) transgenic lenses were explanted. The explants were treated for 20 min with 50 ng/ml EGF (D, E, and F), 100 ng/ml EGF (G, H, and I), or with no
EGF (control; A, B, and C). With no growth factor treatment, the basal levels of pERK1/2 in the central epithelial cells of WT lens, and Spry1GOF and Spry2GOF transgenic lenses
were similar with little to no labeling (A–C). Treatment with 50 ng/ml EGF resulted in an increase in pERK1/2 levels in some isolated central epithelial cells of WT lens
explants (D), with very little increase and lower levels in some cells of Spry1GOF and Spry2GOF lenses (E, F). With 100 ng/ml EGF, central epithelial cells of the WT, Spry1GOF
and Spry2GOF lenses all had similar pERK1/2 labeling, with similar levels and distribution throughout the explant. Scale bar, 10 mm.
E.H. Shin et al. / Developmental Biology 406 (2015) 129–146 145consistent with many of the features previously reported in lens of
mice deﬁcient for ERK2 (Upadhya et al., 2013). This study high-
lights the importance of tightly regulating intracellular signaling
to orchestrate tissue morphogenesis and growth, with ERK1/2
signaling established as a key mediator of lens cellular processes.
This regulation of FGF-induced ERK1/2 phosphorylation by Spry is
important for lens cells, as the strength and duration of growth
factor-induced ERK1/2 activation is reported to determine lens cell
fate (Iyengar et al., 2007; Wang et al., 2010). Spry can negatively
regulate lens cell proliferation and ﬁber cell differentiation in vivo
and in vitro, with Spry playing an important role in the main-
tenance of lens growth and the determination of lens and eye size.Acknowledgment
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